Company profile

BodyVision Medical Ltd.

BodyVision Medical Ltd. has 1 AI-enabled medical device on the FDA list. The first decision was on October 1, 2024 and the most recent on October 1, 2024 (LungVision). Its most common review panel is Radiology (1 device).

1AI devices

2024First decision

2024Latest decision

1Specialties

Timeline

October 1, 2024 · 510(k) K240943LungVision · Radiology · QIH